NCT01895998View on ClinicalTrials.gov

Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Sickle Cell Disease

Interventions

DRUG

Albuterol

This medication will be used as routine part of pulmonary function testing to assess for airway hyperreactivity. This is routinely done in a clinical capacity for pediatric patients with various pulmonary disease processes.

Trial Locations (1)

27710

Duke University Medical Center, Durham